News

Public · Published

Leonardo DRS Selected by AV for U.S. Army's Enduring-High Energy Laser Production Program

Leonardo DRS said AeroVironment selected it to provide rugged integration expertise and power-management and environmental-control support for the U.S. Army's Enduring-High Energy Laser production program. The work supports AeroVironment's production of LOCUST X3 laser systems, intended to help soldiers counter unmanned aircraft threats.

Published:

Updated:

What happened

Leonardo DRS said AeroVironment selected it to provide rugged integration expertise and power-management and environmental-control support for the U.S. Army’s Enduring-High Energy Laser production program. The work supports AeroVironment’s production of LOCUST X3 laser systems, intended to help soldiers counter unmanned aircraft threats.

Confirmed

Global impact / market context

The subcontract links Leonardo DRS to production of a mobile laser weapon, rather than only development work. If production expands, demand for its power and thermal-management support could grow; that could add revenue, though the article gives no contract value or expected contribution.

Analyst inference

The article describes the Army’s program as moving into production and says the 30-kilowatt LOCUST X3 is designed for use across military platforms. This places DRS’s work in a defense procurement effort focused on countering unmanned aircraft, but provides no spending totals or delivery schedule.

Analyst inference

What to watch

  1. Look for contract details, delivery timing, or production quantities from the companies or Army; these would clarify when DRS may begin recognizing revenue from the subcontract. Analyst inference
  2. Watch whether the Army orders further E-HEL systems and whether AV expands production; larger orders could increase demand for DRS’s power and environmental-control subsystems. Analyst inference
  3. Track whether DRS describes the subcontract’s value or expected profit contribution in later disclosures; without those details, investors cannot gauge its financial scale. Analyst inference

Evidence